HIV‐1 expression during early mammalian development

K. J. Whitmer,P. Calarco

DOI: https://doi.org/10.1097/00002030-199210000-00011

1992-10-01

Abstract:ObjectiveOur long-term objective is to determine the consequences of HIV-1 expression in the mammalian fetus using the mouse as a model system. This study describes HIV gene expression in micro-injected and electroporated embryos during the pre-implantation period. DesignProcedures were adopted to create a non-infectious HIV system to assay HIV long terminal repeat (LTR) activation in a non-human mammal. MethodsTwo constructs (RSV promoter-HIV tat gene; HIV LTR-lac Z gene) were co-micro-injected (10 μg/ml each) into pronuclei of fertilized eggs or one nucleus of the two-cell stage and expression assessed after 2–5 days. The techniques of electroporation and micro-injection were compared for their ability to deliver the constructs expressed subsequently. ResultsWe found that HIV-1 expression, as monitored by β-galactosidase production, can occur as early as the eight-cell to blastocyst stage. The intensity of HIV expression varied from high to low; the proportion of the embryo expressing HIV varied from half to only two cells. The material was too limited to allow a determination of integration. ConclusionsThe expression rate of the HIV-LTR was low, averaging slightly over 1%. The data demonstrate that the HIV-LTR can be activated in early mammalian development, even before implantation. This information is valuable to those studying HIV-transgenic mice, to those interested in factors governing HIV expression, and to those concerned about pathologies accompanying developmental expression of HIV.